Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raul Herrera

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Biological Chemistry|July 28, 2009
Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidateMatthew L Plassmeyer, Karine Reiter, Richard L Shimp, et al.
Kidney International. Supplement|August 20, 2005
Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 DeclarationJohn H Dirks, Dick de Zeeuw, Sanjay K Agarwal, et al.
The Journal of Clinical Investigation|February 9, 2021
Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not miceSara A Healy, Charles Anderson, Bruce J Swihart, et al.
Plos One|October 18, 2016
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve AdultsKawsar R Talaat, Ruth D Ellis, Janet Hurd, et al.
NPJ Vaccines|April 15, 2023
Structural and immunological differences in Plasmodium falciparum sexual stage transmission-blocking vaccines comprised of Pfs25-EPA nanoparticlesNicholas J MacDonald, Kavita Singh, Karine Reiter, et al.
Infection and Immunity|July 15, 2015
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion DomainsRaul Herrera, Charles Anderson, Krishan Kumar, et al.
Cardiology Journal|September 7, 2021
Sodium restriction in patients with chronic heart failure and reduced ejection fraction: A randomized controlled trialJuan B Ivey-Miranda, Eduardo Almeida-Gutierrez, Raul Herrera-Saucedo, et al.
BMC Genomics|April 19, 2015
Development and preliminary evaluation of a 90 K Axiom® SNP array for the allo-octoploid cultivated strawberry Fragaria × ananassaNahla V Bassil, Thomas M Davis, Hailong Zhang, et al.
Nature Communications|March 20, 2021
A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametesCamila H Coelho, Wai Kwan Tang, Martin Burkhardt, et al.
JACC. Cardiovascular Interventions|April 21, 2018
Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback Predicts Hemodynamic Outcome In Humans With Coronary Artery Disease: Primary Results of the International Multicenter iFR GRADIENT RegistryYuetsu Kikuta, Christopher M Cook, Andrew S P Sharp, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Biological Chemistry|July 28, 2009
Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidateMatthew L Plassmeyer, Karine Reiter, Richard L Shimp, et al.
Kidney International. Supplement|August 20, 2005
Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 DeclarationJohn H Dirks, Dick de Zeeuw, Sanjay K Agarwal, et al.
The Journal of Clinical Investigation|February 9, 2021
Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not miceSara A Healy, Charles Anderson, Bruce J Swihart, et al.
Plos One|October 18, 2016
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve AdultsKawsar R Talaat, Ruth D Ellis, Janet Hurd, et al.
NPJ Vaccines|April 15, 2023
Structural and immunological differences in Plasmodium falciparum sexual stage transmission-blocking vaccines comprised of Pfs25-EPA nanoparticlesNicholas J MacDonald, Kavita Singh, Karine Reiter, et al.
Infection and Immunity|July 15, 2015
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion DomainsRaul Herrera, Charles Anderson, Krishan Kumar, et al.
Cardiology Journal|September 7, 2021
Sodium restriction in patients with chronic heart failure and reduced ejection fraction: A randomized controlled trialJuan B Ivey-Miranda, Eduardo Almeida-Gutierrez, Raul Herrera-Saucedo, et al.
BMC Genomics|April 19, 2015
Development and preliminary evaluation of a 90 K Axiom® SNP array for the allo-octoploid cultivated strawberry Fragaria × ananassaNahla V Bassil, Thomas M Davis, Hailong Zhang, et al.
Nature Communications|March 20, 2021
A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametesCamila H Coelho, Wai Kwan Tang, Martin Burkhardt, et al.
JACC. Cardiovascular Interventions|April 21, 2018
Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback Predicts Hemodynamic Outcome In Humans With Coronary Artery Disease: Primary Results of the International Multicenter iFR GRADIENT RegistryYuetsu Kikuta, Christopher M Cook, Andrew S P Sharp, et al.
Pageof 5